Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gansmo, L. B."'
Autor:
Knappskog, S., Gansmo, L. B., Dibirova, K., Metspalu, A., Ozcelik, T., Zalloua, P., Mouzaya, F., Bliznetz, E., Balanovsky, O., Lonning, P. E.
Publikováno v:
Oncotarget
Cataloged from PDF version of article. The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3533::0fc0f299ddae781affcb877d33a85f8e
https://hdl.handle.net/11693/12609
https://hdl.handle.net/11693/12609
Autor:
Knappskog, S., Gansmo, L. B., Dibirova, K., Metspalu, A., Cybulski, C., Peterlongo, P., Aaltonen, L., Vatten, L., Romundstad, P., Hveem, K., Devilee, P., Evans, G. D., Lin, D., Camp, G. V., Manolopoulos, V. G., Osorio, A., Milani, L., Ozcelik, T., Zalloua, P., Mouzaya, F., Elena Bliznetz, Balanovska, E., Pocheshkova, E., Kucinskas, V., Atramentova, L., Nymadawa, P., Titov, K., Lavryashina, M., Yusupov, Y., Bogdanova, N., Koshel, S., Zamora, J., Wedge, D. C., Charlesworth, D., Dörk, T., Balanovsky, O., Lønning, P. E.
Publikováno v:
OncoTarget
Scopus-Elsevier
University of Manchester-PURE
ResearcherID
Oncotarget
Knappskog, S, Gansmo, L B, Dibirova, K, Metspalu, A, Cybulski, C, Peterlongo, P, Aaltonen, L, Vatten, L, Romundstad, P, Hveem, K, Devilee, P, Evans, G D, Lin, D, Van Camp, G V, Manolopoulos, V G, Osorio, A, Milani, L, Ozcelik, T, Zalloua, P, Mouzaya, F, Bliznetz, E, Balanovska, E, Pocheshkova, E, Kucinskas, V, Atramentova, L, Nymadawa, P, Titov, K, Lavryashina, M, Yusupov, Y, Bogdanova, N, Koshel, S, Zamora, J, Wedge, D C, Charlesworth, D, Dörk, T, Balanovsky, O & Lønning, P E 2014, ' Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649) ', Oncotarget, vol. 5, no. 18, pp. 8223-8234 . https://doi.org/10.18632/oncotarget.1910
Oncotarget, 5(18), 8223-8234
Europe PubMed Central
University of Helsinki
Scopus-Elsevier
University of Manchester-PURE
ResearcherID
Oncotarget
Knappskog, S, Gansmo, L B, Dibirova, K, Metspalu, A, Cybulski, C, Peterlongo, P, Aaltonen, L, Vatten, L, Romundstad, P, Hveem, K, Devilee, P, Evans, G D, Lin, D, Van Camp, G V, Manolopoulos, V G, Osorio, A, Milani, L, Ozcelik, T, Zalloua, P, Mouzaya, F, Bliznetz, E, Balanovska, E, Pocheshkova, E, Kucinskas, V, Atramentova, L, Nymadawa, P, Titov, K, Lavryashina, M, Yusupov, Y, Bogdanova, N, Koshel, S, Zamora, J, Wedge, D C, Charlesworth, D, Dörk, T, Balanovsky, O & Lønning, P E 2014, ' Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649) ', Oncotarget, vol. 5, no. 18, pp. 8223-8234 . https://doi.org/10.18632/oncotarget.1910
Oncotarget, 5(18), 8223-8234
Europe PubMed Central
University of Helsinki
The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary- and endometrial cancer. Assessing SNP2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::08f740fe57862b8c570499e9bcb0fb2e
https://hdl.handle.net/1956/9550
https://hdl.handle.net/1956/9550